» Articles » PMID: 25878031

Myocardial Infarction Superimposed on Aging: MMP-9 Deletion Promotes M2 Macrophage Polarization

Abstract

In this study, we examined the combined effect of aging and myocardial infarction on left ventricular remodeling, focusing on matrix metalloproteinase (MMP)-9-dependent mechanisms. We enrolled 55 C57BL/6J wild type (WT) and 85 MMP-9 Null (Null) mice of both sexes at 11-36 months of age and evaluated their response at Day 7 post-myocardial infarction. Plasma MMP-9 levels positively linked to age in WT mice (r = .46, p = .001). MMP-9 deletion improved survival (76% for WT vs 88% for Null, p = .021). Post-myocardial infarction, there was a progressive increase in left ventricular dilation with age in WT but not in Null mice. By inflammatory gene array analysis, WT mice showed linear age-dependent increases in three different proinflammatory genes (C3, CCl4, and CX3CL1; all p < .05), whereas Null mice showed increases in three proinflammatory genes (CCL5, CCL9, and CXCL4; all p < .05) and seven anti-inflammatory genes (CCL1, CCL6, CCR1, IL11, IL1r2, IL8rb, and Mif; all p < .05). Compared with WT, macrophages isolated from Null left ventricle infarct demonstrated enhanced expression of anti-inflammatory M2 markers CD163, MRC1, TGF-β1, and YM1 (all p < .05), without affecting proinflammatory M1 markers. In conclusion, MMP-9 deletion stimulated anti-inflammatory polarization of macrophages to attenuate left ventricle dysfunction in the aging post-myocardial infarction.

Citing Articles

The interplay of senescence and MMPs in myocardial infarction: implications for cardiac aging and therapeutics.

Balaraman A, Altamimi A, Babu M, Goyal K, Padmapriya G, Bansal P Biogerontology. 2025; 26(1):46.

PMID: 39832057 DOI: 10.1007/s10522-025-10190-6.


Deleting fibroblast growth factor 2 in macrophages aggravates septic acute lung injury by increasing M1 polarization and inflammatory cytokine secretion.

Yi L, Chen Y, Zhang Y, Huang H, Li J, Qu Y Mol Biomed. 2024; 5(1):50.

PMID: 39436561 PMC: 11496435. DOI: 10.1186/s43556-024-00203-0.


The Senescent Heart-"Age Doth Wither Its Infinite Variety".

Vijayakumar A, Wang M, Kailasam S Int J Mol Sci. 2024; 25(7).

PMID: 38612393 PMC: 11011282. DOI: 10.3390/ijms25073581.


The aged extracellular matrix and the profibrotic role of senescence-associated secretory phenotype.

Mebratu Y, Soni S, Rosas L, Rojas M, Horowitz J, Nho R Am J Physiol Cell Physiol. 2023; 325(3):C565-C579.

PMID: 37486065 PMC: 10511170. DOI: 10.1152/ajpcell.00124.2023.


Whole-transcriptome sequencing analysis reveal mechanisms of Yiqi Huoxue Yangyin (YHY) decoction in ameliorating D-gal-induced cardiac aging.

Wang X, Zhang J, Xiu C, Yang J, Liu Y, Lei Y Aging (Albany NY). 2023; 15(8):2906-2919.

PMID: 37071017 PMC: 10188334. DOI: 10.18632/aging.204532.


References
1.
Keeley E, Boura J, Grines C . Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361(9351):13-20. DOI: 10.1016/S0140-6736(03)12113-7. View

2.
Phatharajaree W, Phrommintikul A, Chattipakorn N . Matrix metalloproteinases and myocardial infarction. Can J Cardiol. 2007; 23(9):727-33. PMC: 2651917. DOI: 10.1016/s0828-282x(07)70818-8. View

3.
Bujak M, Kweon H, Chatila K, Li N, Taffet G, Frangogiannis N . Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. J Am Coll Cardiol. 2008; 51(14):1384-92. PMC: 3348616. DOI: 10.1016/j.jacc.2008.01.011. View

4.
Benezra D . Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci. 1997; 38(12):2433-4. View

5.
Serebruany V, Gurbel P . Effect of thrombolytic therapy on platelet expression and plasma concentration of PECAM-1 (CD31) in patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol. 1999; 19(1):153-8. DOI: 10.1161/01.atv.19.1.153. View